Bayer "only leading pain reliever" to reduce heart attack risk claim supported -- NAD.
This article was originally published in The Tan Sheet
Executive Summary
BAYER "ONLY LEADING" ANALGESIC TO "HELP SAVE YOUR LIFE" CLAIM SUBSTANTIATED, the National Advertising Division of the Council of Better Business Bureaus concludes in its January Case Reports. Based on market share data provided by Bayer Consumer Care, NAD found no reason to take issue with the brand's claim that it is "the only leading pain reliever that can help save your life" by "reducing the risk of another heart attack by up to 50%," the watch- dog group states.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning